If you survived the toughest downturn in biotech history: Congratulations on a job well done. But as we turn to 2025, the job will only get tougher for CEOs and Boards. You don’t have the luxury of time. You must deliver again, even in uncertain markets. Join BioCentury, BIA, and special guests for our second annual CEO and investor dialogue on the sidelines of the Jefferies London Healthcare Conference. Register today. Space is limited.